Colorectal Cancer Clinical Trials in Houston

Showing 261-279 of 279 trials

Antineoplaston Therapy in Treating Patients With Colon Cancer

NCT00003486

RATIONALE: Antineoplastons are naturally occurring substances that may also be made in the laboratory. Antineoplastons may inhibit the growth of cancer cells. PURPOSE: This phase II trial is studying how well antineoplaston therapy works in treating patients with colon cancer.

Stage IV Colon CancerRecurrent Colon CancerAdenocarcinoma of the Colon

Burzynski Research Institute

Houston, Texas, United States

COMPLETEDPhase 2< 1 mile

FR901228 in Treating Patients With Previously Treated Unresectable Locally Advanced or Metastatic Colorectal Cancer

NCT00077337

RATIONALE: Drugs used in chemotherapy, such as FR901228, work in different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: This phase II trial is studying how well FR901228 works in treating patients with unresectable locally advanced or metastatic colorectal cancer.

Colorectal Cancer

SWOG Cancer Research NetworkStarted Apr 2004

Mobile, Alabama, United States • Phoenix, Arizona, United States • Phoenix, Arizona, United States +85 more locations

Antineoplaston Therapy in Treating Patients With Colon Cancer

FR901228 in Treating Patients With Previously Treated Unresectable Locally Advanced or Metastatic Colorectal Cancer

Colorectal Cancer Trials in Other Cities

Neoadjuvant Chemoradiation With RHUMAB VEGF (Avastin) for Rectal Cancer

Interleukin-12 in Treating Patients With Cancer in the Abdomen

Comparison of Sulindac, Aspirin, and Ursodiol in Preventing Colorectal Cancer

Vaccine Therapy in Treating Patients With Cancer of the Gastrointestinal Tract

Comparison of Barium Enema, Computed Tomographic Colonography, and Colonoscopy in Detecting Colon Cancer

SWOG-S9635 Fluorouracil Plus Ethynyluracil in Advanced Colorectal Cancer Not Responded to Fluorouracil

Fluorouracil and Leucovorin With or Without Oxaliplatin in Treating Patients With Recurrent Metastatic Colorectal Cancer

Patient-Reported Outcomes in Long-Term Survivors of Colon and Rectal Cancers

Study of FOLFIRI Plus Cetuximab Plus IMO-2055 in Patients With Colorectal Cancer

Combination Chemotherapy Before or After Surgery in Treating Patients With Colorectal Cancer With Liver Metastases That Could Be Removed By Surgery

Study of XL281 in Adults With Solid Tumors

Phase III Randomized Study of 5-FU, CoFactor, and Avastin vs. 5-FU, LV and Avastin for First-Line Colorectal Cancer.

Combination Chemotherapy Plus Bevacizumab in Treating Patients With Advanced Colorectal Cancer

Oxaliplatin and Capecitabine With or Without an Hepatic Arterial Infusion With Floxuridine in Treating Patients Who Are Undergoing Surgery and/or Ablation for Liver Metastases Due to Colorectal Cancer

Oxaliplatin in Treating Patients With Recurrent Metastatic Colorectal Cancer

Phase 2 Study of ABT-869 in Combination With mFOLFOX6 Versus Bevacizumab in Combination With mFOLFOX6 to Treat Advanced Colorectal Cancer

Study of Oxaliplatin, Capecitabine, and Bevacizumab to Treat Older Patients With Colorectal Cancer

Other Conditions in Houston